277 related articles for article (PubMed ID: 24566695)
41. The impact of European Union law on public health.
Hodgson J
Br J Nurs; 2009 Mar 26-Apr 8; 18(6):378-9. PubMed ID: 19329904
[TBL] [Abstract][Full Text] [Related]
42. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
43. [Healthcare services for people in Lower Saxony (Germany) suffering from a rare disease: Findings from a survey among medical professionals].
Pauer F; Pflaum U; Lührs V; Frank M; Graf von der Schulenburg JM
Z Evid Fortbild Qual Gesundhwes; 2016; 113():36-44. PubMed ID: 27480187
[TBL] [Abstract][Full Text] [Related]
44. European Reference Networks: Share, Care, and Cure-Future or Dream?
Wijnen R; Anzelewicz SM; Petersen C; Czauderna P
Eur J Pediatr Surg; 2017 Oct; 27(5):388-394. PubMed ID: 28977810
[No Abstract] [Full Text] [Related]
45. [European Union health strategy: public health for European people].
Oliva AC
Rev Esp Salud Publica; 2008; 82(3):273-81. PubMed ID: 18711642
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of the Hungarian participation in the 6th European Union Framework Programme for Research, Technological Development and Demonstration in the thematic priority area of the life sciences].
Pörzse G; Temesi A
Orv Hetil; 2007 Jul; 148(29):1361-71. PubMed ID: 17631471
[TBL] [Abstract][Full Text] [Related]
47. [Orphan diseases, rare diseases, time to get mobilised].
Cordier JF
Rev Prat; 2006 Jan; 56(2):123-4. PubMed ID: 16584035
[No Abstract] [Full Text] [Related]
48. Rare diseases and orphan drugs.
Taruscio D; Capozzoli F; Frank C
Ann Ist Super Sanita; 2011; 47(1):83-93. PubMed ID: 21430345
[TBL] [Abstract][Full Text] [Related]
49. Call for a national plan for rare diseases.
Jaffe A; Zurynski Y; Beville L; Elliott E
J Paediatr Child Health; 2010 Jan; 46(1-2):2-4. PubMed ID: 19943870
[TBL] [Abstract][Full Text] [Related]
50. Care for patients with ultra-rare disorders.
Hennekam RC
Eur J Med Genet; 2011; 54(3):220-4. PubMed ID: 21147279
[TBL] [Abstract][Full Text] [Related]
51. [Seven years of the National Action League for People with Rare Diseases : NAMSE - a success story?!].
Halbach A; Schnieders B; Knufmann-Happe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):479-486. PubMed ID: 28337510
[TBL] [Abstract][Full Text] [Related]
52. [Orphan drugs: some legal, ethical and economics aspects].
Pabst JY
Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
[TBL] [Abstract][Full Text] [Related]
53. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
Fears R; Kaufmann S; Ter Meulen V; Zumla A;
Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
[TBL] [Abstract][Full Text] [Related]
54. [Shift of focus in the financing of Hungarian drugs. Reimbursement for orphan drugs for treating rare diseases: financing of enzyme replacement therapy in Hungary].
Szegedi M; Molnár MJ; Boncz I; Kosztolányi G
Orv Hetil; 2014 Nov; 155(44):1735-41. PubMed ID: 25344850
[TBL] [Abstract][Full Text] [Related]
55. [Does the healthcare for rare diseases benefit from the legislative reforms?].
Heyder R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):487-493. PubMed ID: 28289779
[TBL] [Abstract][Full Text] [Related]
56. Rare diseases social epidemiology: analysis of inequalities.
Kole A; Faurisson F
Adv Exp Med Biol; 2010; 686():223-50. PubMed ID: 20824449
[TBL] [Abstract][Full Text] [Related]
57. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
58. The need for worldwide policy and action plans for rare diseases.
Forman J; Taruscio D; Llera VA; Barrera LA; Coté TR; Edfjäll C; Gavhed D; Haffner ME; Nishimura Y; Posada M; Tambuyzer E; Groft SC; Henter JI;
Acta Paediatr; 2012 Aug; 101(8):805-7. PubMed ID: 22519914
[TBL] [Abstract][Full Text] [Related]
59. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
Putkowski S
NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
[No Abstract] [Full Text] [Related]
60. [A review of the nutritional management plans in the member states of the European Union].
Lachat C; Dehenauw S; van Camp J; Matthys C; Larondelle Y; Kolsteren P
Verh K Acad Geneeskd Belg; 2006; 68(1):55-76. PubMed ID: 16610423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
